Cart
Account
Your Orders
Sign In
Meet the Team Engineering the Future
Synthego is a pioneering force in the biotechnology industry, leveraging our expertise to deliver cutting-edge CRISPR and advanced Molecular Diagnostics solutions—all in pursuit of improved human health.
High-quality, scalable solutions for CRISPR research, molecular biology and diagnostic workflows
Accelerating cell and gene therapy with pioneering solutions
Synthego is a pioneering force in the biotechnology industry, leveraging our expertise to deliver cutting-edge CRISPR and advanced Molecular Diagnostics solutions—all in pursuit of improved human health.
Engineered Cytosine Base Editor eliminates double-strand breaks for safer, more efficient CRISPR-based therapeutics.
Rapid and accurate RNA amplification and real-time fluorescence for RNA-based diagnostics.
Bringing high fidelity and affordability to your breakthrough cell & gene therapy.
Proven GMP-grade SpCas9 nuclease for your CRISPR-based therapeutics.
Reliable DNA amplification with endpoint detection and results in minutes.
Engineered RNA polymerase, generating high yields of RNA for mRNA therapeutics.
Base editors have promised safer CRISPR therapies, but their clinical translation has faltered owing to their off-target activity. Now, Synthego has partnered with Kactus Biosciences to commercialize AccuBase™ , an...
Synthego is expanding its core mission to accelerate life sciences research and clinical development with the launch of a comprehensive portfolio of high-performance molecular reagents. Building upon our established leadership...
Curious about base editing but not sure where to begin? We’ll break it down step by step, making it easy to follow and apply!